.After rearing $213 million in 2023-- some of the year's most extensive personal biotech shots-- Vol...
.Accept to this week's Chutes & Ladders, our summary of significant leadership hirings, shootings...
.Equity capital financing right into biopharma rose to $9.2 billion around 215 deals in the 2nd one-...
.Bicara Therapeutics and also Zenas Biopharma have actually delivered new motivation to the IPO mark...
.Genentech will close its cancer cells immunology analysis team, and unit head and distinguished tis...
.Kezar Life Sciences is actually losing its dim phase 1 solid lump medication as the biotech goes al...
.In spite of izokibep sustaining its newfound winning touch in the medical clinic, Acelyrin is no mo...
.Rivus Pharmaceuticals has actually plumped up the prospects of its fat-busting, muscle-sparing medi...
.Ovid Therapeutics actually showed final month that it was actually trimming back its own headcount ...
.Eli Lilly has opened up a $700 million R&D facility in the Boston Port, boosting its RNA as well...